Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
A ratio of the two biomarkers detected by the 30-minute clinical chemistry assays can be used for prognosis and treatment of preeclampsia.
Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split
Aspira Women's Health has been evaluating Dana-Farber's microRNA technology for ovarian cancer detection since early 2021.
Becton Dickinson Gets FDA 510(k) Clearance for High-Throughput Vaginitis Test
The BD Vaginal Panel, which tests for the three most common vaginitis pathogens, is the third assay for the high-throughput, fully automated BD Cor system.
Sema4 Exiting Reproductive Health Screening, Cutting 500 More Jobs in Latest Restructuring
The company also reported that its Q3 revenue rose 93 percent to $83.2 million, beating the Wall Street consensus estimate.
Careviso Closes $17.4M Series B Funding Round
The startup company, formerly called CMT Solutions, has developed software to automate prior authorization for diagnostic testing.
Jul 14, 2021
Sera Prognostics Goes Public With $75M IPO
Oct 13, 2020
Enzo Biochem Q4 Revenues Down 7 Percent
Feb 6, 2020
Jan 31, 2020
NeuMoDx T. Vaginalis, M. Genitalium Assay CE Marked
Apr 16, 2019
Home-Based Testing Firm EverlyWell Raises $50M
Mar 11, 2019
Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent
Dec 10, 2018
Enzo Biochem Fiscal Q1 Revenues Down 21 Percent
Nov 27, 2018
Novacyt, Genesis Diagnostics Ink Supply Deal
Nov 15, 2018
Oct 15, 2018